Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.495
+0.115 (4.83%)
Oct 29, 2026, 11:44 AM EDT - Market open
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Acumen Pharmaceuticals the 34,006th largest employer in the world and 4,510th in the United States.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,704,295
Market Cap
180.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 0 | - | 60 | 1 |
| Dec 31, 2024 | 61 | 9 | 17.31% | 61 | 0 |
| Dec 31, 2023 | 52 | 12 | 30.00% | 51 | 1 |
| Dec 31, 2022 | 40 | 23 | 135.29% | 39 | 1 |
| Dec 31, 2021 | 17 | 10 | 142.86% | 14 | 3 |
| Mar 31, 2021 | 7 | - | - | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| Coherus Oncology | 144 |
| Adagene | 128 |
| Invivyd | 122 |
| MediWound | 121 |
| Upstream Bio | 75 |
| PepGen | 57 |
| ALX Oncology Holdings | 48 |
ABOS News
- 2 days ago - Acumen files $500M mixed securities shelf - TheFly
- 3 days ago - Acumen Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Acumen Pharmaceuticals Earnings release: Q3 2026 - Filings
- 3 days ago - Acumen Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 3 days ago - Acumen Pharmaceuticals Registration statement: Registration filing - Filings
- 3 days ago - Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 3 days ago - Acumen Pharmaceuticals Slides: Corporate presentation - Filings
- 7 days ago - Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference - GlobeNewsWire